Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Telix Further Strengthens European Distribution Network for Illuccix 2022-04-22 07:10
First Patients Dosed with Illuccix® - Telix's Approved Prostate Cancer Imaging Agent 2022-04-14 19:00
ProstACT Update: TARGET Study Ethics Approval 2022-04-12 07:47
Telix Pharmaceuticals Announces Licence Agreement with Lilly for Olaratumab 2022-04-11 06:51
PSMA-PET Imaging to be Funded through Medicare in Australia from July 2022 2022-04-06 12:47
Telix, GMS and Monash Awarded $23M Federal Government Funding as part of $71M Australian Precision Medicine Enterprise (APME) Project 2022-04-04 09:13
Commercial Launch: Illuccix® Now Available to Order in the United States 2022-04-04 07:06
Change of Composition of the Telix Board of Directors 2022-03-31 07:11
New Video Series "PSMA PET/CT TODAY" Discusses the Future of Prostate Cancer Care with Leading Experts 2022-03-29 19:00
Telix Granted FDA Orphan Drug Designation for Bone Marrow Conditioning Treatment 2022-03-29 13:34
Telix and Xiel Sign U.K. and Ireland Distribution Agreement for Illuccix® 2022-03-29 07:39
Telix Advances Development of Glioblastoma Therapy Program 2022-03-23 10:16
1 3 4 5 6 7